[
  {
    "patient_ID": "TCGA.KL.8323",
    "drug_therapy_name": "LYMPHOCYTE INFUSION",
    "pharmaceutical_therapy_type.1": "IMMUNOTHERAPY",
    "days_to_drug_start": 880,
    "pharmaceutical_tx_ongoing": false,
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.KL.8323",
    "drug_therapy_name": "VATALANIB",
    "pharmaceutical_therapy_type.1": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 911,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 942,
    "therapy_on_clinical_trial": true
  },
  {
    "patient_ID": "TCGA.KL.8336",
    "drug_therapy_name": "SUNITINIB",
    "pharmaceutical_therapy_type.1": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 138,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 559,
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.KL.8336",
    "drug_therapy_name": "TEMSIROLIMUS",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 558,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 817,
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.KL.8336",
    "drug_therapy_name": "BEVACIZUMAB",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 824,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 838,
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.KL.8339",
    "drug_therapy_name": "SUNITINIB",
    "pharmaceutical_therapy_type.1": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 111,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 251,
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.KL.8341",
    "drug_therapy_name": "SUNITINIB",
    "pharmaceutical_therapy_type.1": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 196,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 366,
    "therapy_on_clinical_trial": true
  },
  {
    "patient_ID": "TCGA.KL.8341",
    "drug_therapy_name": "BEVACIZUMAB",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 196,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 366,
    "therapy_on_clinical_trial": true
  },
  {
    "patient_ID": "TCGA.KL.8341",
    "drug_therapy_name": "SUNITINIB",
    "pharmaceutical_therapy_type.1": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 397,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 457,
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.KL.8341",
    "drug_therapy_name": "TEMSIROLIMUS",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 567,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 609,
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.KL.8341",
    "drug_therapy_name": "SORAFENIB",
    "pharmaceutical_therapy_type.1": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 624,
    "pharmaceutical_tx_ongoing": false,
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.KM.8438",
    "drug_therapy_name": "SUNITINIB",
    "pharmaceutical_therapy_type.1": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 2342,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 2731,
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.KM.8438",
    "drug_therapy_name": "TEMSIROLIMUS",
    "pharmaceutical_therapy_type.1": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 2731,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 4436,
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.KM.8438",
    "drug_therapy_name": "BEVACIZUMAB",
    "pharmaceutical_therapy_type.1": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 3554,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 3858,
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.KM.A7Q8",
    "drug_therapy_name": "SUNITINIB",
    "pharmaceutical_therapy_type.1": "TARGETED MOLECULAR THERAPY",
    "pharmaceutical_tx_ongoing": false,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.KN.8426",
    "drug_therapy_name": "BEVACIZUMAB",
    "pharmaceutical_therapy_type.1": "TARGETED MOLECULAR THERAPY",
    "pharmaceutical_tx_ongoing": false,
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.KN.8426",
    "drug_therapy_name": "SORAFENIB",
    "pharmaceutical_therapy_type.1": "TARGETED MOLECULAR THERAPY",
    "pharmaceutical_tx_ongoing": false,
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.KN.8428",
    "drug_therapy_name": "SORAFENIB",
    "pharmaceutical_therapy_type.1": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 510,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 638,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.KO.8404",
    "drug_therapy_name": "THALIDOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 117,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 139,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": true
  },
  {
    "patient_ID": "TCGA.UW.A7GR",
    "drug_therapy_name": "INTERFERON",
    "pharmaceutical_therapy_type.1": "IMMUNOTHERAPY",
    "days_to_drug_start": 22,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 288,
    "treatment_best_response": "PARTIAL RESPONSE",
    "therapy_on_clinical_trial": true
  },
  {
    "patient_ID": "TCGA.UW.A7GR",
    "drug_therapy_name": "SORAFENIB",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 22,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 288,
    "treatment_best_response": "PARTIAL RESPONSE",
    "therapy_on_clinical_trial": true
  }
]
